Tianjin, China

Jing Long

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Accendatech, Nankai University. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jing Long. Retrieved from https://idiyas.com/inventor/jing-long

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jing Long in Drug Technology

Introduction

Jing Long is an accomplished inventor based in Tianjin, China. He has made significant contributions to the field of drug technology, particularly through his innovative research and development of pharmaceutical compounds.

Latest Patents

Jing Long holds a patent for the "Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation." This invention focuses on the applications of sesquiterpene lactone compounds in preparing drugs, specifically targeting treatments for rheumatoid arthritis and cancers by inhibiting cancer stem cells. His work represents a notable advancement in drug preparation technology.

Career Highlights

Throughout his career, Jing Long has worked with notable organizations such as Accendatech and Nankai University. His experience in these institutions has allowed him to further his research and contribute to the scientific community.

Collaborations

Jing Long has collaborated with esteemed colleagues, including Yue Chen and Quan Zhang. Their joint efforts have enhanced the research and development of innovative drug solutions.

Conclusion

Jing Long's contributions to drug technology through his patent and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…